Citius Pharmaceuticals Stock (NASDAQ: CTXR) stock price, news, charts, stock research, profile.
You can purchase shares of Citius Pharmaceuticals (NASDAQ:CTXR) through any online brokerage.
Other companies in Citius Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP), Addex Therapeutics (NASDAQ:ADXN) and Kiora Pharmaceuticals (NASDAQ:KPRX).
Citius Pharmaceuticals has a consensus price target of $6.33.
The stock price for Citius Pharmaceuticals (NASDAQ: CTXR) is $1.85 last updated February 21, 2025 at 10:31 AM EST.
There are no upcoming dividends for Citius Pharmaceuticals.
Citius Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, May 13, 2025.
There is no upcoming split for Citius Pharmaceuticals.
Citius Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.